NADPH oxidase gene therapy (Genethon)
- Generic Name
- NADPH oxidase gene therapy (Genethon)
Lentiviral Gene Therapy for p47 AR-CGD
Phase 1
Recruiting
- Conditions
- P47-Phox, Deficiency of
- Interventions
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2023-05-16
- Target Recruit Count
- 5
- Registration Number
- NCT05207657
- Locations
- 🇬🇧
Great Ormond Street Hospital, London, United Kingdom
Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Phase 1
Recruiting
- Conditions
- Severe Combined Immunodeficiency, X-Linked
- Interventions
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2023-10-12
- Target Recruit Count
- 5
- Registration Number
- NCT03601286
- Locations
- 🇬🇧
Great Ormond Street Hospital for Children NHS Foundation Trust, London, Greater London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath